Skip to main content
. 2020 Jul 25;20:347. doi: 10.1186/s12872-020-01627-6

Table 1.

Characteristics of study participants

Characteristics Survey-1 (Nanjing) Survey-2 (Hefei) Pooled data
Participants, n 5824 20,269 26,093
Age, years 52.0 (43.0 to 59.0) 51.0 (43.0 to 58.0) 51.0 (43.0 to 58.0)
Women, n (%) 3278 (56.3) 11,905 (58.7) 15,183 (58.2)
Current smoking, n (%) 1571 (28.0) 4687 (23.3) 6258 (24.0)
Hypertension, n (%) 2259 (38.8) 9228 (45.5) 11,487 (44.0)
Type 2 diabetes, n (%) 472 (8.1) 1832 (9.0) 2304 (8.8)
Body mass index, kg/m2 23.6 (21.4 to 26.1) 24.1 (21.8 to 26.5) 24.0 (22.1 to 26.8)
Waist circumference, cm 80.0 (73.3 to 87.0) 81.6 (74.3 to 88.7) 81.3 (74.0 to 88.4)
Systolic blood pressure, mmHg 128 (116 to 143) 132 (120 to 148) 131 (119 to 147)
Diastolic blood pressure, mmHg 80.5 (73.5 to 88.5) 82.5 (75.0 to 90.5) 82.0 (75.0 to 90.0)
Fasting glucose, mmol/L 5.4 (4.9 to 5.9) 5.3 (4.8 to 5.2) 5.3 (4.8 to 5.8)
Triglyceride, mmol/L 1.2 (0.8 to 1.7) 1.3 (0.9 to 1.8) 1.2 (0.9 to 1.8)
Total cholesterol, mmol/L 4.4 (3.9 to 4.9) 4.6 (4.0 to 5.2) 4.5 (4.0 to 5.1)
High density lipoprotein cholesterol, mmol/L 1.3 (1.1 to 1.5) 1.3 (1.1 to 1.5) 1.3 (1.1 to 1.5)
Low density lipoprotein cholesterol, mmol/L 2.4 (2.0 to 2.9) 2.6 (2.2 to 3.1) 2.5 (2.1 to 3.0)
Dyslipidaemia, n (%) 2583 (44.4) 10,463 (51.6) 13,046 (50.0)
Overweight, n (%) 2341 (40.2) 9187 (45.3) 11,528 (44.2)
Having ≥1 CVD modifiable risk factor, n (%) 4692 (80.6) 17,118 (84.5) 21,810 (83.6)
Having ≥2 CVD modifiable risk factors, n (%) 2914 (50.0) 11,421 (56.4) 14,335 (54.9)
Having ≥3 CVD modifiable risk factors, n (%) 1275 (21.9) 5422 (26.8) 6697 (25.7)

Continuous variables were presented as median (interquartile range); categorical variables were presented as number (percentage)